| Literature DB >> 29851748 |
Anna Sondell1,2, Erik Rosendahl1,2, Yngve Gustafson2, Nina Lindelöf1,2, Håkan Littbrand1,2.
Abstract
BACKGROUND ANDEntities:
Mesh:
Year: 2019 PMID: 29851748 PMCID: PMC6791515 DOI: 10.1519/JPT.0000000000000199
Source DB: PubMed Journal: J Geriatr Phys Ther ISSN: 1539-8412 Impact factor: 3.381
Correlations Between Outcome Variables and Medical Conditionsa
| Variable | Attendance Rate | High-Intensity Strength Rate | High-Intensity Balance Rate | Adverse Event Rate |
|---|---|---|---|---|
| MMSE | –0.016 | 0.182 | 0.153 | 0.027 |
| GDS-15 | 0.009 | 0.014 | 0.163 | 0.057 |
| NPI, total | –0.217 | –0.150 | –0.295 | 0.063 |
| NPI, apathy | –0.216 | 0.067 | 0.055 | –0.082 |
| BBS | 0.055 | –0.001 | 0.093 | –0.085 |
| MNA | –0.026 | 0.028 | –0.048 | –0.061 |
| Pain while walking | 0.016 | –0.119 | 0.013 | 0.215 |
| Analgesic use | –0.064 | –0.183 | –0.041 | 0.238 |
| Neuroleptic use | 0.185 | 0.107 | 0.185 | 0.036 |
| Heart failure | –0.025 | 0.175 | 0.040 | –0.006 |
| Angina pectoris | –0.107 | 0.223 | 0.034 | 0.049 |
| Chronic lung disease | –0.193 | 0.043 | –0.094 | 0.091 |
| Vision impairment | 0.166 | –0.070 | –0.178 | 0.053 |
| Hearing impairment | 0.077 | 0.074 | –0.164 | 0.026 |
| Sex (female) | 0.043 | –0.097 | –0.016 | 0.148 |
Abbreviations: BBS, Berg Balance Scale; GDS-15, 15-item Geriatric Depression Scale; MMSE, Mini-Mental State Examination; MNA, Mini Nutritional Assessment; NPI, Neuropsychiatric Inventory.
aSpearman rank correlations used in analyses.
bP < .05.
cP < .01.
Figure 1.Flowchart of the study. ADLs indicates activities of daily living; MMSE, Mini-Mental State Examination.
Baseline Characteristics of Participantsa
| Characteristic | Total (n = 93) | AD (n = 34) | Non-AD (n = 59) |
|---|---|---|---|
| Age, y | 84.4 (6.2) | 84.9 (6.6) | 84.1 (6.0) |
| Sex, female | 70 (75.3) | 27 (79.4) | 43 (72.9) |
| Dementia type | |||
| Alzheimer's | 34 (36.6) | ||
| Vascular | 36 (38.7) | ||
| Mixed AD/vascular | 8 (8.6) | ||
| Other | 15 (16.1) | ||
| Diagnoses and medical conditions | |||
| Depressive disorders | 53 (57.0) | 18 (52.9) | 35 (59.3) |
| Delirium, previous week | 48 (51.6) | 15 (44.1) | 33 (55.9) |
| Previous stroke | 33 (35.5) | 3 (8.8) | 30 (50.8) |
| Heart failure | 24 (25.8) | 6 (17.6) | 18 (30.5) |
| Angina pectoris | 21 (22.6) | 5 (14.7) | 16 (27.1) |
| Previous hip fracture | 28 (30.1) | 7 (20.6) | 21 (35.6) |
| Diabetes mellitus | 18 (19.4) | 6 (17.6) | 12 (20.3) |
| Rheumatic disease | 14 (15.1) | 4 (11.8) | 10 (16.9) |
| Chronic lung disease | 20 (21.5) | 6 (17.6) | 14 (23.7) |
| Osteoarthritis | 35 (37.6) | 12 (35.3) | 23 (39.0) |
| Hearing impairment | 20 (21.5) | 9 (26.5) | 11 (18.6) |
| Vision impairment | 10 (10.8) | 6 (17.6) | 4 (6.8) |
| Pain while walking, n = 90 | 15 (16.1) | 7 (20.6) | 8 (13.6) |
| Prescription medications | |||
| Analgesics | 55 (59.1) | 19 (55.9) | 36 (61.0) |
| Antidepressants | 58 (62.4) | 22 (64.7) | 36 (61.0) |
| Benzodiazepine | 19 (20.4) | 8 (23.5) | 11 (18.6) |
| Diuretics | 41 (44.1) | 13 (38.2) | 28 (47.5) |
| Cholinesterase inhibitor | 25 (26.9) | 13 (38.2) | 12 (20.3) |
| Neuroleptics | 11 (11.8) | 5 (14.7) | 6 (10.2) |
| Number of medications | 8.4 (4.0) | 7.3 (3.6) | 9.1 (4.1) |
| Assessments | |||
| Barthel ADL Index (0-20) | 10.7 (4.5) | 11.0 (4.5) | 10.6 (4.5) |
| MMSE (range: 0-30) | 15.4 (3.4) | 14.4 (3.0) | 16.0 (3.6) |
| Berg Balance Scale (range: 0-56) | 28.6 (14.3) | 33.2 (12.9) | 25.9 (14.5) |
| Gait speed: 4 m, m/s, n = 88 | 0.45 (0.2) | 0.5 (0.2) | 0.45 (0.2) |
| NPI (range: 0-144) | 15.2 (15.8) | 15.7 (12.9) | 15.0 (17.4) |
| NPI apathy (range: 0-12) | 0.97 (2.2) | 0.47 (1.4) | 1.3 (2.5) |
| GDS-15 (range: 0-15) | 4.0 (3.4) | 3.2 (3.0) | 4.4 (3.5) |
| MNA (range: 0-30) | 21.3 (2.8) | 21.1 (2.9) | 21.3 (2.7) |
| Use of mobility device | 76 (81.7) | 21 (61.8) | 55 (93.2) |
| Self-reported health, good | 60 (62.5) | 21 (61.8) | 39 (66.1) |
Abbreviations: ADL, activities of daily living; GDS-15, 15-item Geriatric Depression Scale; MMSE, Mini-Mental State Examination; MNA, Mini Nutritional Assessment; NPI, Neuropsychiatric Inventory.
aValues are expressed as mean (SD) or as n (%). Numbers reported after covariates indicate numbers of measures available when values are missing.
bReported by staff based on the confusion subscales of the Organic Brain Syndrome Scale.
cP < .01.
dUnable to hear conversation from 1-m distance with or without hearing aid.
eP < .05.
fHigher scores indicate better status.
gLower scores indicate better status.
Figure 2.Attendance, high-intensity strength, high-intensity balance, and adverse event rates in participants with AD and non-AD dementia. aP < .05, AD versus non-AD. AD indicates Alzheimer's disease.
Figure 3.Reasons for not attending exercise sessions, as percentage of total sessions. aIncludes anxiety, restlessness, and delirium.
Figure 4.Reasons for not achieving high intensity, as percentage of all attended sessions. More than 1 reason per participant could be recorded. aIncluded in the pain category.
Figure 5.Reasons for not achieving high intensity in strength exercises in participants with AD and non-AD dementia, as percentage of all attended sessions. More than 1 reason per participant could be recorded. aIncluded in the pain category. AD indicates Alzheimer's disease.